Literature DB >> 16557301

Convergence of Itch-induced ubiquitination with MEKK1-JNK signaling in Th2 tolerance and airway inflammation.

K Venuprasad1, Chris Elly, Min Gao, Shahram Salek-Ardakani, Yohsuke Harada, Jun-Li Luo, Chun Yang, Michael Croft, Kazushi Inoue, Michael Karin, Yun-Cai Liu.   

Abstract

The immune system is capable of mounting robust responses against invading pathogens but refrains from attacking self. Many studies have focused on tolerance induction of Th1 cells, whose failure results in development of autoimmune diseases. However, the molecular mechanisms governing tolerance induction in Th2 cells and its relation to allergic responses remain unclear. Here we used both in vivo and in vitro protocols to demonstrate that Th2 cells either containing a mitogen and extracellular kinase kinase 1 (MEKK1) mutant or lacking JNK1 or the E3 ubiquitin ligase Itch cannot be tolerized. In a mouse allergic model, injection of high-dose tolerizing antigen failed to block the development of airway inflammation in Itch-/- mice. This study suggests that MEKK1-JNK signaling regulates Itch E3 ligase-mediated tolerogenic process in Th2 cells. These findings have therapeutic implications for allergic diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16557301      PMCID: PMC1409741          DOI: 10.1172/JCI26858

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  41 in total

Review 1.  Themes and variations on ubiquitylation.

Authors:  A M Weissman
Journal:  Nat Rev Mol Cell Biol       Date:  2001-03       Impact factor: 94.444

Review 2.  Tolerance and autoimmunity.

Authors:  T Kamradt; N A Mitchison
Journal:  N Engl J Med       Date:  2001-03-01       Impact factor: 91.245

Review 3.  The enemy within: keeping self-reactive T cells at bay in the periphery.

Authors:  Lucy S K Walker; Abul K Abbas
Journal:  Nat Rev Immunol       Date:  2002-01       Impact factor: 53.106

Review 4.  Mechanisms underlying ubiquitination.

Authors:  C M Pickart
Journal:  Annu Rev Biochem       Date:  2001       Impact factor: 23.643

5.  Dysregulation of T lymphocyte function in itchy mice: a role for Itch in TH2 differentiation.

Authors:  Deyu Fang; Chris Elly; Baixue Gao; Nan Fang; Yoav Altman; Claudio Joazeiro; Tony Hunter; Neal Copeland; Nancy Jenkins; Yun-Cai Liu
Journal:  Nat Immunol       Date:  2002-02-04       Impact factor: 25.606

6.  Signaling through OX40 (CD134) breaks peripheral T-cell tolerance.

Authors:  P Bansal-Pakala; A G Jember; M Croft
Journal:  Nat Med       Date:  2001-08       Impact factor: 53.440

7.  JNK is required for effector T-cell function but not for T-cell activation.

Authors:  C Dong; D D Yang; C Tournier; A J Whitmarsh; J Xu; R J Davis; R A Flavell
Journal:  Nature       Date:  2000-05-04       Impact factor: 49.962

8.  Recognition and ubiquitination of Notch by Itch, a hect-type E3 ubiquitin ligase.

Authors:  L Qiu; C Joazeiro; N Fang; H Y Wang; C Elly; Y Altman; D Fang; T Hunter; Y C Liu
Journal:  J Biol Chem       Date:  2000-11-17       Impact factor: 5.157

Review 9.  Asthma: an epidemic of dysregulated immunity.

Authors:  Dale T Umetsu; Jennifer J McIntire; Omid Akbari; Claudia Macaubas; Rosemarie H DeKruyff
Journal:  Nat Immunol       Date:  2002-08       Impact factor: 25.606

10.  Transcriptional mechanisms underlying lymphocyte tolerance.

Authors:  Fernando Macián; Francisco García-Cózar; Sin-Hyeog Im; Heidi F Horton; Michael C Byrne; Anjana Rao
Journal:  Cell       Date:  2002-06-14       Impact factor: 41.582

View more
  45 in total

1.  GRAIL (gene related to anergy in lymphocytes) regulates cytoskeletal reorganization through ubiquitination and degradation of Arp2/3 subunit 5 and coronin 1A.

Authors:  Daiju Ichikawa; Miho Mizuno; Takashi Yamamura; Sachiko Miyake
Journal:  J Biol Chem       Date:  2011-10-20       Impact factor: 5.157

Review 2.  Itch regulation of innate and adaptive immune responses in mice and humans.

Authors:  Natania S Field; Emily K Moser; Paula M Oliver
Journal:  J Leukoc Biol       Date:  2020-04-30       Impact factor: 4.962

Review 3.  The E3 ubiquitin ligase Itch in T cell activation, differentiation, and tolerance.

Authors:  Yun-Cai Liu
Journal:  Semin Immunol       Date:  2007-04-11       Impact factor: 11.130

Review 4.  Physiological functions of the HECT family of ubiquitin ligases.

Authors:  Daniela Rotin; Sharad Kumar
Journal:  Nat Rev Mol Cell Biol       Date:  2009-05-13       Impact factor: 94.444

Review 5.  Cbl- and Nedd4-family ubiquitin ligases: balancing tolerance and immunity.

Authors:  Denise L Gay; Hilda Ramón; Paula M Oliver
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

Review 6.  Multifaceted role of the ubiquitin ligase Itch in immune regulation.

Authors:  K Venuprasad; Minghui Zeng; Scott L Baughan; Ramin Massoumi
Journal:  Immunol Cell Biol       Date:  2015-01-13       Impact factor: 5.126

Review 7.  Ubiquitin Ligases in Cancer Immunotherapy - Balancing Antitumor and Autoimmunity.

Authors:  Yu Fujita; Roberto Tinoco; Yan Li; Daniela Senft; Ze'ev A Ronai
Journal:  Trends Mol Med       Date:  2019-03-18       Impact factor: 11.951

Review 8.  Ubiquitous points of control over regulatory T cells.

Authors:  Fan Pan; Joseph Barbi
Journal:  J Mol Med (Berl)       Date:  2014-04-29       Impact factor: 4.599

9.  Ndfip1 mediates peripheral tolerance to self and exogenous antigen by inducing cell cycle exit in responding CD4+ T cells.

Authors:  John A Altin; Stephen R Daley; Jason Howitt; Helen J Rickards; Alison K Batkin; Keisuke Horikawa; Simon J Prasad; Keats A Nelms; Sharad Kumar; Lawren C Wu; Seong-Seng Tan; Matthew C Cook; Christopher C Goodnow
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-13       Impact factor: 11.205

10.  Nuclear translocation of MEK1 triggers a complex T cell response through the corepressor silencing mediator of retinoid and thyroid hormone receptor.

Authors:  Lei Guo; Chaoyu Chen; Qiaoling Liang; Mohammad Zunayet Karim; Magdalena M Gorska; Rafeul Alam
Journal:  J Immunol       Date:  2012-12-05       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.